Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-08-18

FDA Approved: FEMRING — Supplemental Application (Millicent US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for FemRing (estradiol acetate vaginal ring) from Millicent US, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FEMRING (Estradiol acetate)

Snippet

SUPPL AP for FEMRING (ESTRADIOL ACETATE)